Abstract
Hepatocellular carcinoma (HCC) is the most common primary malignant neoplasm of the liver. It develops with underlying liver cirrhosis or chronic hepatitis in most patients. Detection of HCC is critical in the follow-up of patients with chronically damaged livers. Although dynamic spiral computed tomography (CT) is a sensitive choice for detecting HCC (1), magnetic resonance (MR) imaging is increasingly applied for the detection of all hepatic lesions, especially HCC lesions in patients with chronic liver disease, and the use of contrast agents has the potential to increase the sensitivity and spesificity of hepatic MR imaging.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
